CEL-SCI Eulerpool News

CEL-SCI Aktie News

CEL-SCI wird von vielen Journalisten und Investoren weltweit beobachtet. Die aktuellsten CEL-SCI News stellen wir hier zusammen.

• 14. Juli ·

  Yahoo
  CEL-SCI Announces Closing of $5.7 Million Offering Priced At-The-Market Under NYSE American Rules
• 31. Dezember ·

  Yahoo
  CEL-SCI Announces Closing of $5 Million Offering
• 30. Dezember ·

  Yahoo
  CEL-SCI Announces Pricing of $5 Million Public Offering
• 12. Dezember ·

  Yahoo
  CEL-SCI Highlights Biological Rationale for the Use of Multikine in the Confirmatory Registration Head and Neck Cancer Study
• 9. Dezember ·

  Yahoo
  CVM: CRO Selected for Registrational Trial
• 8. November ·

  SeekingAlpha
  Stock Picks From Seeking Alpha's October 2024 New Analysts
• 25. Oktober ·

  Seeking Alpha
  CEL-SCI files to sell 1M shares of common stock for holders
• 22. Oktober ·

  Yahoo
  FDA’s Oncologic Drugs Advisory Committee Decision on Checkpoint Inhibitors Substantiates Potential of CEL-SCI’s Multikine® to Address Major Treatment Gap for PD-L1 Negative Cancer Patients
• 22. Oktober ·

  TipRanks
  CEL-SCI announces potential impact on Multikine following FDA ODAC meeting
• 1. Oktober ·

  Yahoo
  CEL-SCI Selects Ergomed as CRO as it Gears Up for Confirmatory FDA Registration Study of Multikine® in Head and Neck Cancer